MISSION clinical trials
The partners and stakeholders involved in clinical research in Quebec are coming together as part of a large-scale collective project to ensure Quebec (Canada) is recognised as a global hub for Early Stage Clinical Trials
An inpiring vision
CATALIS’ vision is to ensure that Quebec (Canada) is globally recognized for its excellence in conducting early stage clinical trials.
A federative mission
CATALIS’ federally mandated mission is to bring together all of Quebec’s life sciences stakeholders – hospitals, government agencies, pharmaceutical companies, and organizations – to maximize private investments and to ensure positive human, economic and social benefits.
By 2022, CATALIS’ goal is twofold: double the amount that private industry invests in early stage clinical research in Quebec and offer more patients early access to innovative healthcare.
To meet these goals, focus is placed on three strategic elements:
- Operational Excellence
- Clinical Leadership
- Networking and coordination